The formation of TEOXANE Australia will further the global expansion of the TEOXANE SA innovative and high-end filler range for aesthetic medicine.
TEOXANE SA, Swiss laboratories specialising in hyaluronic acid (HA) dermal fillers, has announced the formation of TEOXANE Australia. After more than four years of successful partnership with Mondeal, the Australian-based Distributing Partner, TEOXANE will now be setting up its own operations in Australia as a wholly-owned subsidiary to further fuel the development of TEOXANE’s market share in Australia. TEOXANE Australia is the ninth subsidiary of the Swiss hyaluronic acid expert, after France, Germany, UK, Spain, Poland, Switzerland, Russia and Italy.
TEOXANE Australia will be led by Krishna Sai, Vice President APAC (a known aesthetic business leader in APAC) with Richard Arnott on his management team, responsible for the commercial operations. The current Mondeal staff will transition into TEOXANE team to ensure continuity of customer support in Australia. With this latest business transition TEOXANE Australia looks forward to continue to grow the business through world class Medical education and with focused campaigns to help build on the success of our customers.
TEOXANE Laboratories was established in Geneva, Switzerland, in 2003 and is specialised in the design and manufacture of hyaluronic acid-based dermal fillers and cosmetic products. Since its inception in 2003, the foundation of the company has been based on integrated research and development under its founder and CEO Valérie Taupin.
TEOXANE’s dedication to innovation and excellence allows a strong growth platform in the rapidly changing Aesthetics environment. While maintaining the status as an independently-owned company, TEOXANE has a significant global presence in over 90 countries worldwide with over 12 million syringes injected to date. The pursuit of excellence, embedded in the DNA of TEOXANE, is what has been driving TEOXANE since the beginning in order to both reach patients’ satisfaction and earn partners’ trust.
For more information call Peta Roberts 1800 633 830